Chirag Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chirag Patel has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Avani Raulji2 shared publications
- Devjani Banerjee
GSFC University
2 shared publications - Himanshu Pandya
Professor, Department of Medicine, Pramukhswami Medical College, Karamsad, Anand, Gujarat, India
2 shared publications - Jainikkumar Patel2 shared publications
- Rupal Patel
Pramukhswami Medical College, Bhaikaka University, Karamsad Medical College, Anand, India
2 shared publications - Siddhi A. Darji
Department of Life Sciences, School of Science, GSFC University, Vadodara, India
2 shared publications
Latest Publications
- Open Access
- 2 August 2026
- Published by Elsevier in SSRN Electronic Journal
Diagnostic Accuracy of the Resist-5 O.K.N.V.I. Immunochromatographic Assay for Detection of Carbapenemase-Producing Gram-Negative Bacteria: Comparison with Real-Time PCR
Gram-negative bacteria resistant to carbapenems have now become a major global health threat due to limited therapeutic options and high mortality. Rapid and meticulous detection of carbapenemase genes is crucial for targeted antimicrobial treatment and infection control. This study evaluated the diagnostic performance of the Resist-5 O.K.N.V.I. immunochromatographic test (ICT) compared with Real-time polymerase chain reaction (RT-PCR) to detect major carbapenemase genes. A prospective diagnostic accuracy study included 252 clinical isolates of Gram-negative bacteria resistant to carbapenem. The ICT assay was evaluated for detection of five major carbapenemase genes (blaNDM, blaKPC, blaVIM, blaIMP, blaOXA-48), using RT-PCR as the reference standard. Sensitivity, Specificity, Positive Predictive Value (PPV), and Negative Predictive Value (NPV) were calculated. The Gene-level ICT assay showed a sensitivity of 99.66% and a specificity of 99.90%, with a PPV of 99.66%, and an NPV of 99.90%. Overall agreement between ICT and RT-PCR was excellent (Cohen’s kappa = 0.996). The Resist-5 O.K.N.V.I. ICT assay is a quick, reliable, and economical detection device for screening of major carbapenemase genes. Nevertheless, molecular tests are still necessary for confirmatory testing.
- 2 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDiagnostic Accuracy of the Resist-5 O.K.N.V.I. Immunochromatographic Assay for Detection of Carbapenemase-Producing Gram-Negative Bacteria: Comparison with Real-Time PCR
Gram-negative bacteria resistant to carbapenems have now become a major global health threat due to limited therapeutic options and high mortality. Rapid and meticulous detection of carbapenemase genes is crucial for targeted antimicrobial treatment and infection control. This study evaluated the diagnostic performance of the Resist-5 O.K.N.V.I. immunochromatographic test (ICT) compared with Real-time polymerase chain reaction (RT-PCR) to detect major carbapenemase genes. A prospective diagnostic accuracy study included 252 clinical isolates of Gram-negative bacteria resistant to carbapenem. The ICT assay was evaluated for detection of five major carbapenemase genes (blaNDM, blaKPC, blaVIM, blaIMP, blaOXA-48), using RT-PCR as the reference standard. Sensitivity, Specificity, Positive Predictive Value (PPV), and Negative Predictive Value (NPV) were calculated. The Gene-level ICT assay showed a sensitivity of 99.66% and a specificity of 99.90%, with a PPV of 99.66%, and an NPV of 99.90%. Overall agreement between ICT and RT-PCR was excellent (Cohen’s kappa = 0.996). The Resist-5 O.K.N.V.I. ICT assay is a quick, reliable, and economical detection device for screening of major carbapenemase genes. Nevertheless, molecular tests are still necessary for confirmatory testing.
- 7 January 2026
- Published by Springer Nature in Biologia
- Vol. 81 (1) , 3
Anti-biofilm activity of Bacillus safensis subsp. osmophilus SD2 against multidrug resistant hospital isolates of ESKAPE group
- 7 January 2026
- Published by Springer Nature in Biologia
- Vol. 81 (1) , 3
Anti-biofilm activity of Bacillus safensis subsp. osmophilus SD2 against multidrug resistant hospital isolates of ESKAPE group